H.R. 7902 · 119th Congress · House

To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.

Active· Introduced in House
Introduced
Mar 12, 26
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Action Timeline

4
  1. MAR 12, 2026•IntroReferral

    Introduced in House

  2. MAR 12, 2026•IntroReferral

    Introduced in House

  3. MAR 12, 2026•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. MAR 12, 2026•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

2

Judiciary Committee

hsju00

Referred: Mar 12, 2026

Active

Energy and Commerce Committee

hsif00

Referred: Mar 12, 2026

Active